Compare Cetrorelix (evidence A) and Kisspeptin (evidence C) on mechanism, clinical status, safety, and dosing.
Cetrorelix is a synthetic GnRH antagonist decapeptide (MW ~1431.1 g/mol) FDA-approved for the prevention of premature LH surges in women undergoing controlled…
Kisspeptin is an endogenous neuropeptide encoded by the KISS1 gene that plays a critical role in regulating reproductive hormone secretion. It binds GPR54…
Full profiles: Cetrorelix, Kisspeptin.